Nasdaq agrx.

Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Agile Therapeutics, Inc. (AGRX) NasdaqCM - NasdaqCM Real... AGRX Earnings Date and Information. Agile Therapeutics last issued its quarterly earnings results on August 9th, 2023. The specialty pharmaceutical company reported ($3.10) earnings per share for the quarter, beating analysts' consensus estimates of ($3.48) by $0.38. The firm had revenue of $5.50 million for the quarter, compared to the ...Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will ...

... Nasdaq Listing Rule 5635(c)(4). GlobeNewswire Oct 4, 2023 1:30pm. Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group.Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript. Mar 30, 2022.

Jun 28, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...

Find the latest Insider Activity data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...PRINCETON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it will participate in the RHK Capital Disruptive ...Agile Therapeutics (NASDAQ:AGRX) Now Covered by Analysts at StockNews.com americanbankingnews.com - November 26 at 2:52 AM: Agile Therapeutics (NASDAQ:AGRX) Stock Crosses Below 200 Day Moving Average of $2.67 americanbankingnews.com - November 25 at 3:54 AM: Agile Therapeutics reports Q3 results msn.com - November 23 at 8:51 AMPRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that it has updated its second quarter 2022 Twirla demand (total ...

AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further dec Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the ...

Find the latest Insider Activity data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.

PRINCETON, N.J., May 25, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ...Agile Therapeutics Inc. (NASDAQ: AGRX) During trading and after-hours, AGRX stock managed to shoot up by over 10% and 10.4% respectively. And, this is even more impressive following its six month drop of over 90%. For similar reasons that EVFM stock climbed, AGRX is a women’s health focused biotech penny stock.Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.May 25, 2023 · PRINCETON, N.J., May 25, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ... PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...

The Nasdaq Stock Market requires companies to maintain a minimum share price of $1. And yet 464 companies listed on the exchange were trading for less than $1 …PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the granting of a previously disclosed inducement award ...Agile Therapeutics Inc. (AGRX) is down over 4% at $2.74 in pre-market hours Monday on no news. The company's birth control patch Twirla is expected to be launched this quarter.(NASDAQ: AGRX) forecast ROE is N/A, which is considered weak. What is AGRX's Price Target? According to 2 Wall Street analyst s that have issued a 1 year AGRX price target, the average AGRX price target is $8.50 , with the highest AGRX stock price forecast at $12.00 and the lowest AGRX stock price forecast at $5.00 .PRINCETON, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three and twelve months ended ...PRINCETON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that a meeting of the Bone, Reproductive and Urologic ...NASDAQ: AGRX · IEX Real-Time Price · USD. Add to Watchlist 2.16 +0.09 (4.35%) Dec 1, 2023, 4:00 PM EST - Market closed. Overview; Financials; ... Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for AGRX stock stock is $8.50, which predicts an increase of 293.52%. The lowest target is …

27 Feb 2023 ... PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare ...

Agile Therapeutics Inc (NASDAQ: AGRX) was in 6 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic is 15. Our calculations also showed that AGRX ...AGRX Earnings Date and Information. Agile Therapeutics last issued its quarterly earnings results on August 9th, 2023. The specialty pharmaceutical company reported ($3.10) earnings per share for the quarter, beating analysts' consensus estimates of ($3.48) by $0.38. The firm had revenue of $5.50 million for the quarter, compared to the ...PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180 …PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after ...Agile Therapeutics Inc (NASDAQ:AGRX) Agile Therapeutics Inc. 1.90. Delayed Data. As of Nov 14. -0.02 / -1.04%. Today’s Change. 1.65. Today ||| 52-Week Range.AGRX Option Chain. ... Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month ...Detailed Share Price, Charts and News for Agile Therapeutics Inc [NASDAQ,AGRX]. Share Market Tools for Successful Investing. Global Share Market database ...PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...Apr 19, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...

As previously announced, the Company was notified by Nasdaq on August 15, 2022 that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), as ...

NASDAQ. NASDAQ pulled back as traders took profits in tech stocks. NVIDIA is down by 3.3% as traders worry that company’s sales in China would decline …

Webull offers Agile Therapeutics Inc stock information, including NASDAQ: AGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate …According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ...AGRX Sales Forecast. Next quarter’s sales forecast for AGRX is $9.20M with a range of $9.20M to $9.20M. The previous quarter’s sales results were $6.66M. AGRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.22% of the time in the same period. Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ... PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that data from the company’s first-year of ...Find the latest Revenue & EPS data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Agile Therapeutics, Inc. Common Stock (AGRX) Historical Closing Prices - View free historical Nasdaq official closing price data at Nasdaq.com.Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. Add/Edit Symbols Edit …PRINCETON, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended June 30, 2022 ...PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial ...

Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00.Dec 1, 2023 · Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the granting of a previously disclosed inducement award to the... Apr 26, 2022 · The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX." Instagram:https://instagram. best dental plan for bracesinteractive brokers stockamt reitatandt postpaid Oct 21, 2022 · NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 Published. Oct 21, 2022 11:00am EDT. Benzinga Digital Content Studio--News Direct--Contact Details. otc jamn1943 steel wheat penny price Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million. netsuite net worth The purchase of more than 5.73 million Agile Therapeutics Inc (NASDAQ:AGRX) shares by a beneficial owner at about $0.85 apiece totaled over $4.87 million. The owner's stake in this contraceptives ...Aug 9, 2023 · PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ... PRINCETON, N.J., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued ...